A computer image showing a model of the coronavirus that causes COVID-19. Image: NEXU Science Communication/via REUTERS
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
- Scientists say twin studies illuminating possible genetic influence of COVID-19 must be interpreted with caution
- Immune response to COVID-19 differs from other respiratory infections
- Evidence mounts for air pollution link to severity of illness
Twin studies should be interpreted with caution
A recent (unpublished) study comparing the symptoms of identical and non-identical twins infected with COVID-19 concluded that COVID-19 symptoms appear to be around 50% genetic. The findings were based on data collected from over 2,600 twins via the COVID-19 Symptom Tracker app developed by a team at King’s College London.
Scientists not involved in the study have told the public to exercise caution when interpreting the findings from this and other studies of siblings, because it can be hard to tease apart environmental and genetic influences on disease outcome, particularly if people live in the same household. Scientists also warn that media coverage of twin deaths can also distort public perceptions of risk via a psychological effect known as salience bias, where we put too much emphasis on what we find striking.
Abnormal immune response to COVID-19
As we have seen in the past two months, not all comparisons between the current coronavirus, SARS-CoV-2, and other respiratory illnesses like the flu, are helpful. Yet, scientists continue to learn more about the virus by researching its similarities and differences to better understood viruses.
This week, scientists at the Icahn School of Medicine at Mount Sinai in New York discovered that cells infected with SARS-CoV-2 produce unusually low levels of antiviral proteins called interferons compared with cells infected with other respiratory viruses. At the same time, levels of proteins that activate more general immune responses were higher in infected individuals than healthy people.
Taken together, the findings, soon to be published in the journal Cell, suggest an immune imbalance, that could explain the unique signature of the disease: low levels of interferons reduce a cell’s ability to stop the virus replicating itself and the activation of less-specific immune responses promotes inflammation.
The study supports the idea that treatments targeting the immune system could help people with COVID-19.
Could air pollution be making COVID-19 worse?
It’s not gone unnoticed that some of the worst-hit areas, such as northern Italy, are also highly polluted, and several studies are starting to point towards air pollution amplifying the severity of COVID-19.
“We don’t have the evidence linking directly to mortality yet, but we know if you are exposed to air pollution you are increasing your chances of being more severely affected,” said Dr María Neira, Director of Public Health at the World Health Organization (WHO).
Preliminary studies show that air pollution could be important in three ways:
- Death rates are higher in heavily polluted areas because individuals’ heart and lungs are already weakened by dirty air.
- Pollutants inflame the lungs potentially making people more likely to catch the virus.
- Pollution particles might help carry the virus further.
None of these studies have yet been peer-reviewed and researchers caution against implying causation from the correlation between air pollution and severity of COVID-19. The main risk of catching COVID-19 is still being in contact with an infected person but further research into the role that air pollution plays could help to better respond to the pandemic, especially as many countries are beginning to lift lockdown measures.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
More on COVID-19See all
January 8, 2024
October 11, 2023
August 8, 2023
Simon Nicholas Williams
May 9, 2023
Philip Clarke, Jack Pollard and Mara Violato
April 17, 2023